CPT: Pharmacometrics & Systems Pharmacology (Nov 2021)
Development of best practices in physiologically based pharmacokinetic modeling to support clinical pharmacology regulatory decision‐making—A workshop summary
- Daphney Jean,
- Kunal Naik,
- Lauren Milligan,
- Stephen Hall,
- Shiew Mei Huang,
- Nina Isoherranen,
- Colleen Kuemmel,
- Paul Seo,
- Million A. Tegenge,
- Yaning Wang,
- Yuching Yang,
- Xinyuan Zhang,
- Liang Zhao,
- Ping Zhao,
- Jessica Benjamin,
- Kimberly Bergman,
- Joseph Grillo,
- Rajanikanth Madabushi,
- Fang Wu,
- Hao Zhu,
- Issam Zineh
Affiliations
- Daphney Jean
- Office of Clinical Pharmacology Office of Translational Sciences Center for Drug Evaluation and Research US Food and Drug Administration Silver Spring Maryland USA
- Kunal Naik
- Office of Clinical Pharmacology Office of Translational Sciences Center for Drug Evaluation and Research US Food and Drug Administration Silver Spring Maryland USA
- Lauren Milligan
- Office of Clinical Pharmacology Office of Translational Sciences Center for Drug Evaluation and Research US Food and Drug Administration Silver Spring Maryland USA
- Stephen Hall
- Eli Lilly and Company Indianapolis Indiana USA
- Shiew Mei Huang
- Office of Clinical Pharmacology Office of Translational Sciences Center for Drug Evaluation and Research US Food and Drug Administration Silver Spring Maryland USA
- Nina Isoherranen
- School of Pharmacy University of Washington Seattle Washington USA
- Colleen Kuemmel
- Office of Clinical Pharmacology Office of Translational Sciences Center for Drug Evaluation and Research US Food and Drug Administration Silver Spring Maryland USA
- Paul Seo
- Office of Pharmaceutical Quality Center for Drug Evaluation and Research US Food and Drug Administration Silver Spring Maryland USA
- Million A. Tegenge
- Office of Tissues and Advanced Therapies Center for Biologics Evaluation and Research US Food and Drug Administration Silver Spring Maryland USA
- Yaning Wang
- Office of Clinical Pharmacology Office of Translational Sciences Center for Drug Evaluation and Research US Food and Drug Administration Silver Spring Maryland USA
- Yuching Yang
- Office of Clinical Pharmacology Office of Translational Sciences Center for Drug Evaluation and Research US Food and Drug Administration Silver Spring Maryland USA
- Xinyuan Zhang
- Office of Clinical Pharmacology Office of Translational Sciences Center for Drug Evaluation and Research US Food and Drug Administration Silver Spring Maryland USA
- Liang Zhao
- Office of Generic Drugs Center for Drug Evaluation and Research US Food and Drug Administration Silver Spring Maryland USA
- Ping Zhao
- Bill & Melinda Gates Foundation Seattle Washington USA
- Jessica Benjamin
- Office of Clinical Pharmacology Office of Translational Sciences Center for Drug Evaluation and Research US Food and Drug Administration Silver Spring Maryland USA
- Kimberly Bergman
- Office of Clinical Pharmacology Office of Translational Sciences Center for Drug Evaluation and Research US Food and Drug Administration Silver Spring Maryland USA
- Joseph Grillo
- Office of Clinical Pharmacology Office of Translational Sciences Center for Drug Evaluation and Research US Food and Drug Administration Silver Spring Maryland USA
- Rajanikanth Madabushi
- Office of Clinical Pharmacology Office of Translational Sciences Center for Drug Evaluation and Research US Food and Drug Administration Silver Spring Maryland USA
- Fang Wu
- Office of Generic Drugs Center for Drug Evaluation and Research US Food and Drug Administration Silver Spring Maryland USA
- Hao Zhu
- Office of Clinical Pharmacology Office of Translational Sciences Center for Drug Evaluation and Research US Food and Drug Administration Silver Spring Maryland USA
- Issam Zineh
- Office of Clinical Pharmacology Office of Translational Sciences Center for Drug Evaluation and Research US Food and Drug Administration Silver Spring Maryland USA
- DOI
- https://doi.org/10.1002/psp4.12706
- Journal volume & issue
-
Vol. 10,
no. 11
pp. 1271 – 1275
Abstract
No abstracts available.